Look for:

Our offer for

GLAXOSMITHKLINE PLC (GSKH) - EUX/20230317


2022/08/12 18:52:35
Price
1,420.1884 GBp
Difference 3.38% (46.39)

General attributes

SymbolGSKHH23
ExchangeEurex
CurrencyGBp
Security typeFuture
UnderlyingGSK PLC
Maturity03-2023
Contract size1,000

Market data

Bid (Bid size)- GBp (-)
Ask (Ask size)- GBp (-)
Open1,420.1884 GBp
High1,420.1884 GBp
Low1,420.1884 GBp
Close (prev. day)1,373.8024 GBp
UnderlyingGSK PLC
Underlying price (date)1,450.00 (22/08/12)
Settlement price (date)1,420.19 (22/08/12)
Open Interest0

Performance and Risk

6m1Y3Y
Perf (%)---
Perf (abs.)---
Beta---
Volatility28.5128.5128.51

Futures and Options

Related Futures-
Related Options-
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)1,503.7894 GBp (0)
Ø price 30 days | Ø volume 30 days (pcs.)1,675.9883 GBp (0)
Ø price 100 days | Ø volume 100 days (pcs.)1,698.6006 GBp (0)
Ø price 250 days | Ø volume 250 days (pcs.)- GBp (0)
YTD High | date1,803.2589 GBp (2022/07/04)
YTD Low | date1,373.8024 GBp (2022/08/11)
52 Weeks High | date1,803.2589 GBp (2022/07/04)
52 Weeks Low | date1,373.8024 GBp (2022/08/11)

Recent Research

Date Headline Download
2022/08/08 en Global Equity Ratings PDF Download
2022/07/25 en Global Equity Ratings PDF Download
2022/07/19 en Global Equity Ratings PDF Download
2022/06/29 en Global Equity Ratings PDF Download
2022/05/25 en Global Equity Ratings PDF Download




Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer